- RWE has emerged as a valuable complementary resource to provide information beyond what is learned from randomized clinical trials
- Advances in technology and analytics are enabling real-world data to be gathered in real time and analyzed to help make clinical, payer, policy, and regulatory decisions
- The capability of RWE to create a more robust view of the benefits and risks of oncology treatments among all patients eligible for therapy is critically important
to learn more.
SVMPharma is an innovative strategic consultancy and CRO, with a focus in Real World Evidence (RWE) for pharmaceutical and biotechnology companies. SVMPharma delivers clinical trials within UK and Europe.
DISTILL is a new EDC launched by SVMPharma. As a CRO discover the benefits of DISTILL as part of your service offering and take back control of your clinical trials. DISTILL allows you to develop and manage every aspect of your trials from start to finish. Move away from the restrictions and costs associated with legacy systems.
For more information, please visit www.svmpharma.com
and contact us at email@example.com